Cargando…

Pharmaceutical induction of ApoE secretion by multipotent mesenchymal stromal cells (MSCs)

BACKGROUND: Apolipoprotein E (ApoE) is a molecular scavenger in the blood and brain. Aberrant function of the molecule causes formation of protein and lipid deposits or "plaques" that characterize Alzheimer's disease (AD) and atherosclerosis. There are three human isoforms of ApoE des...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zeitouni, Suzanne, Ford, Brian S, Harris, Sean M, Whitney, Mandolin J, Gregory, Carl A, Prockop, Darwin J
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2008
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2596794/ https://www.ncbi.nlm.nih.gov/pubmed/18823563 http://dx.doi.org/10.1186/1472-6750-8-75

Ejemplares similares

Human Multipotent Stromal Cells (MSCs) Increase Neurogenesis and Decrease Atrophy of the Striatum in a Transgenic Mouse Model for Huntington's Disease
por: Snyder, Brooke R., et al.
Publicado: (2010)

The human arthritic hip joint is a source of mesenchymal stromal cells (MSCs) with extensive multipotent differentiation potential
por: Wagenbrenner, Mike, et al.
Publicado: (2020)

Human multipotent stromal cells attenuate lipopolysaccharide-induced acute lung injury in mice via secretion of tumor necrosis factor-α-induced protein 6
por: Danchuk, Svitlana, et al.
Publicado: (2011)

Evolving paradigms for repair of tissues by adult stem/progenitor cells (MSCs)
por: Prockop, Darwin J, et al.
Publicado: (2010)

Rapidly Self-Renewing Human Multipotent Marrow Stromal Cells (hMSC) Express Sialyl Lewis X and Actively Adhere to Arterial Endothelium in a Chick Embryo Model System
por: McFerrin, Harris E., et al.
Publicado: (2014)

Short-Term Exposure of Multipotent Stromal Cells to Low Oxygen Increases Their Expression of CX3CR1 and CXCR4 and Their Engraftment In Vivo
por: Hung, Shih-Chieh, et al.
Publicado: (2007)

Mesenchymal stem cells/multipotent stromal cells (MSCs) are glycolytic and thus glucose is a limiting factor of in vitro models of MSC starvation
por: Nuschke, Austin, et al.
Publicado: (2016)

Sternal bone marrow derived equine multipotent mesenchymal stromal cells (MSCs): investigations considering the sampling site and the use of different culture media
por: Eydt, Carina, et al.
Publicado: (2016)

A three-dimensional (3D), serum-free, Collagen Type I system for chondrogenesis of canine bone marrow-derived multipotent stromal cells (cMSCs)
por: MacIver, Melissa A., et al.
Publicado: (2022)

Growth Factor-Mediated Tenogenic Induction of Multipotent Mesenchymal Stromal Cells Is Altered by the Microenvironment of Tendon Matrix
por: Roth, Susanne Pauline, et al.
Publicado: (2018)

CRISPR/Cas9-mediated reversibly immortalized mouse bone marrow stromal stem cells (BMSCs) retain multipotent features of mesenchymal stem cells (MSCs)
por: Hu, Xue, et al.
Publicado: (2017)

Regulation of Immunity via Multipotent Mesenchymal Stromal Cells
por: Rubtsov, Y. P., et al.
Publicado: (2012)

Allogeneic Mesenchymal Stromal Cells (MSCs) are of Comparable Efficacy to Syngeneic MSCs for Therapeutic Revascularization in C57BKSdb/db Mice Despite the Induction of Alloantibody
por: Liew, A., et al.
Publicado: (2018)

The developmental basis of mesenchymal stem/stromal cells (MSCs)
por: Sheng, Guojun
Publicado: (2015)

Multipotent Mesenchymal Stromal Cells: Possible Culprits in Solid Tumors?
por: Johann, Pascal David, et al.
Publicado: (2015)

GPCRs in the regulation of the functional activity of multipotent mesenchymal stromal cells
por: Chechekhin, Vadim I., et al.
Publicado: (2022)

Identification of a Candidate Proteomic Signature to Discriminate Multipotent and Non-Multipotent Stromal Cells
por: Rosu-Myles, Michael, et al.
Publicado: (2012)

Interleukin-25 Mediates Transcriptional Control of PD-L1 via STAT3 in Multipotent Human Mesenchymal Stromal Cells (hMSCs) to Suppress Th17 Responses
por: Wang, Wei-Bei, et al.
Publicado: (2015)

Meniscus Regeneration With Multipotent Stromal Cell Therapies
por: Zhou, Yun-Feng, et al.
Publicado: (2022)

Optimizing conditions for labeling of mesenchymal stromal cells (MSCs) with gold nanoparticles: a prerequisite for in vivo tracking of MSCs
por: Nold, Philipp, et al.
Publicado: (2017)

Senescence induces fundamental changes in the secretome of mesenchymal stromal cells (MSCs): implications for the therapeutic use of MSCs and their derivates
por: Siraj, Yesuf, et al.
Publicado: (2023)

Fibrogenic Potential of Human Multipotent Mesenchymal Stromal Cells in Injured Liver
por: Baertschiger, Reto M., et al.
Publicado: (2009)

Functional Characteristics of Multipotent Mesenchymal Stromal Cells from Pituitary Adenomas
por: Megnis, Kaspars, et al.
Publicado: (2016)

The therapeutic potential of three-dimensional multipotent mesenchymal stromal cell spheroids
por: Petrenko, Yuriy, et al.
Publicado: (2017)

Proteomic Profiling of the Human Fetal Multipotent Mesenchymal Stromal Cells Secretome
por: Lobov, Arseniy A., et al.
Publicado: (2020)

Neural differentiation of canine mesenchymal stem cells/multipotent mesenchymal stromal cells
por: Prpar Mihevc, Sonja, et al.
Publicado: (2020)

Are MSCs angiogenic cells? New insights on human nestin-positive bone marrow-derived multipotent cells
por: Pacini, Simone, et al.
Publicado: (2014)

Adult multipotent stromal cell cryopreservation: Pluses and pitfalls
por: Duan, Wei, et al.
Publicado: (2017)

Editorial: Multipotent stromal cells and microenvironment of the tissue healing
por: Lotfy, Ahmed, et al.
Publicado: (2023)

Correction to: Optimizing conditions for labeling of mesenchymal stromal cells (MSCs) with gold nanoparticles: a prerequisite for in vivo tracking of MSCs
por: Nold, Philipp, et al.
Publicado: (2019)

Are Clinical Trials With Mesenchymal Stem/Progenitor Cells too Far Ahead of the Science? Lessons From Experimental Hematology
por: Prockop, Darwin J, et al.
Publicado: (2014)

Deterministic and stochastic approaches in the clinical application of mesenchymal stromal cells (MSCs)
por: Pacini, Simone
Publicado: (2014)

Correction: Fibrogenic Potential of Human Multipotent Mesenchymal Stromal Cells in Injured Liver
por: Baertschiger, Reto M., et al.
Publicado: (2009)

Cytoplasmic-targeted parvalbumin blocks the proliferation of multipotent mesenchymal stromal cells in prophase
por: Melo, Carolina Soares Barros, et al.
Publicado: (2013)

Stability enhancement of clinical grade multipotent mesenchymal stromal cell-based products
por: Mirabel, Clémentine, et al.
Publicado: (2018)

Scalable Production of Equine Platelet Lysate for Multipotent Mesenchymal Stromal Cell Culture
por: Hagen, A., et al.
Publicado: (2021)

Phospholipid Profiles for Phenotypic Characterization of Adipose-Derived Multipotent Mesenchymal Stromal Cells
por: Burk, Janina, et al.
Publicado: (2021)

Multipotent Mesenchymal Stromal Cells Interact and Support Islet of Langerhans Viability and Function
por: Koehler, Naomi, et al.
Publicado: (2022)

Human multipotent mesenchymal stromal cells cytokine priming promotes RAB27B-regulated secretion of small extracellular vesicles with immunomodulatory cargo
por: Cheng, Anastasia, et al.
Publicado: (2020)

Multipotent Stromal Cells and Viral Interaction: Current Implications for Therapy
por: Taechangam, Nopmanee, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_bk65kv3dqttfd5iu5agn3g09hv